Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants

C Liu, X Zhuo, FJ Gonzalez and X Ding

Laboratory of Human Toxicology and Molecular Epidermiology, Wadsworth Center, New York State Department of Health, New York, USA.

Cytochrome P450 2A3 (CYP2A3) was previously identified in rat lung by cDNA cloning and recently found to be expressed at a high level in the olfactory mucosa. In the current study, CYP2A3 was expressed in insect cells lacking endogenous cytochrome P450 (P450) activity, and the substrate specificity of the recombinant cytochrome was characterized and compared with that of CYP2A6, a human ortholog of rat CYP2A3, which has been detected in human olfactory mucosa as well as in liver. The CYP2A3 and CYP2A6 cDNAs were cloned into baculovirus, and recombinant viruses were used to produce active enzymes in Spodoptera frugiperta (SF9) cells. The metabolic activities of S. frugiperta cell microsomal fractions containing CYP2A3 or CYP2A6 were studied in a reconstituted system with purified rabbit NADPH-P450 reductase. CYP2A3 was found to be active toward testosterone, producing 15 alpha-hydroxytestosterone and several other metabolites, but it had only low activity toward coumarin. On the other hand, CYP2A6 was active toward coumarin but not toward testosterone. However, both enzymes were active in the metabolic activation of hexamethylphosphoramide, a nasal procarcinogen, and 2,6- dichlorobenzonitrile (DCBN), a herbicide known to cause tissue-specific toxicity in the olfactory mucosa of rodents at very low doses. In addition, both enzymes were active toward 4-nitrophenol, a preferred substrate for CYP2E1. Consistent with CYP2A3 being a major catalyst in microsomal metabolism of DCBN, the activities of both CYP2A3 and rat olfactory microsomes in DCBN metabolism were inhibited strongly by metyrapone and methoxsalen (ID50 < 1 microM, with DCBN at 30 microM), but only marginally by 4-methylpyrazole, an inhibitor of CYP2E1. In contrast, the activity of CYP2A6 was only weakly inhibited by metyrapone or methoxsalen (ID50 > 50 microM). Thus, rat CYP2A3 and human CYP2A6 have differences in substrate specificity as well as tissue distributor. These findings should be taken into account when assessing the risk of exposure to potential nasal toxicants in humans.

Volume 50, Issue 4, pp. 781-788, 10/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				X. Zhang, J. D'Agostino, H. Wu, Q.-Y. Zhang, L. von Weymarn, S. E. Murphy, and X. Ding CYP2A13: Variable Expression and Role in Human Lung Microsomal Metabolic Activation of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 570 - 578. [Abstract] [Full Text] [PDF]

				A. M. Jeffrey, M. J. Iatropoulos, and G. M. Williams Nasal Cytotoxic and Carcinogenic Activities of Systemically Distributed Organic Chemicals Toxicol Pathol, December 1, 2006; 34(7): 827 - 852. [Abstract] [Full Text] [PDF]

				M. B. Genter Molecular Biology of the Nasal Airways: How Do We Assess Cellular and Molecular Responses in the Nose? Toxicol Pathol, April 1, 2006; 34(3): 274 - 280. [Abstract] [Full Text] [PDF]

				A. Franzen, C. Carlsson, V. Hermansson, M. Lang, and E. B. Brittebo CYP2A5-MEDIATED ACTIVATION AND EARLY ULTRASTRUCTURAL CHANGES IN THE OLFACTORY MUCOSA: STUDIES ON 2,6-DICHLOROPHENYL METHYLSULFONE Drug Metab. Dispos., January 1, 2006; 34(1): 61 - 68. [Abstract] [Full Text] [PDF]

				S. E. Murphy, V. Raulinaitis, and K. M. Brown NICOTINE 5'-OXIDATION AND METHYL OXIDATION BY P450 2A ENZYMES Drug Metab. Dispos., August 1, 2005; 33(8): 1166 - 1173. [Abstract] [Full Text] [PDF]

				A.-L. Minn, H. Pelczar, C. Denizot, M. Martinet, J.-M. Heydel, B. Walther, A. Minn, H. Goudonnet, and Y. Artur CHARACTERIZATION OF MICROSOMAL CYTOCHROME P450-DEPENDENT MONOOXYGENASES IN THE RAT OLFACTORY MUCOSA Drug Metab. Dispos., August 1, 2005; 33(8): 1229 - 1237. [Abstract] [Full Text] [PDF]

				L. B. von Weymarn, Q.-Y. Zhang, X. Ding, and P. F. Hollenberg Effects of 8-methoxypsoralen on cytochrome P450 2A13 Carcinogenesis, March 1, 2005; 26(3): 621 - 629. [Abstract] [Full Text] [PDF]

				E. Piras, A. Franzen, E. L. Fernandez, U. Bergstrom, F. Raffalli-Mathieu, M. Lang, and E. B. Brittebo Cell-specific Expression of CYP2A5 in the Mouse Respiratory Tract: Effects of Olfactory Toxicants J. Histochem. Cytochem., November 1, 2003; 51(11): 1545 - 1555. [Abstract] [Full Text] [PDF]

				J. R. Jalas, X. Ding, and S. E. Murphy COMPARATIVE METABOLISM OF THE TOBACCO-SPECIFIC NITROSAMINES 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL BY RAT CYTOCHROME P450 2A3 AND HUMAN CYTOCHROME P450 2A13 Drug Metab. Dispos., October 1, 2003; 31(10): 1199 - 1202. [Abstract] [Full Text] [PDF]

				X. Zhang, T. Su, Q.-Y. Zhang, J. Gu, M. Caggana, H. Li, and X. Ding Genetic Polymorphisms of the Human CYP2A13 Gene: Identification of Single-Nucleotide Polymorphisms and Functional Characterization of an Arg257Cys Variant J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 416 - 423. [Abstract] [Full Text] [PDF]

				R. N. Hines and D. G. McCarver The Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative Enzymes J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 355 - 360. [Abstract] [Full Text] [PDF]

				S. C. Chen, L. Zhou, X. Ding, and S. S. Mirvish Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3 Drug Metab. Dispos., September 1, 2001; 29(9): 1221 - 1228. [Abstract] [Full Text] [PDF]

				S. E. Murphy, I. S. Isaac, X. Ding, and E. J. McIntee Specificity of Cytochrome P450 2A3-Catalyzed alpha -Hydroxylation of N'-Nitrosonornicotine Enantiomers Drug Metab. Dispos., November 1, 2000; 28(11): 1263 - 1266. [Abstract] [Full Text]

				M. B. Genter, D. M. Burman, M. W. Dingeldein, I. Clough, and B. Bolon Evolution of Alachlor-Induced Nasal Neoplasms in the Long-Evans Rat Toxicol Pathol, November 1, 2000; 28(6): 770 - 781. [Abstract] [PDF]

				T. Su, Z. Bao, Q.-Y. Zhang, T. J. Smith, J.-Y. Hong, and X. Ding Human Cytochrome P450 CYP2A13: Predominant Expression in the Respiratory Tract and Its High Efficiency Metabolic Activation of a Tobacco-specific Carcinogen, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Cancer Res., September 1, 2000; 60(18): 5074 - 5079. [Abstract] [Full Text]

				R. Gopalakrishnan, M. A. Morse, J. Lu, C. M. Weghorst, C. L.K. Sabourin, G. D. Stoner, and S. E. Murphy Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine Carcinogenesis, May 1, 1999; 20(5): 885 - 891. [Abstract] [Full Text] [PDF]

				X. Zhuo, J. Gu, Q.-Y. Zhang, D. C. Spink, L. S. Kaminsky, and X. Ding Biotransformation of Coumarin by Rodent and Human Cytochromes P-450: Metabolic Basis of Tissue-Selective Toxicity in Olfactory Mucosa of Rats and Mice J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 463 - 471. [Abstract] [Full Text]

				S. C. Chen, X. Wang, G. Xu, L. Zhou, J. L. Vennerstrom, F. Gonzalez, H. V. Gelboin, and S. S. Mirvish Depentylation of [3H-pentyl]Methyl-n-amylnitrosamine by Rat Esophageal and Liver Microsomes and by Rat and Human Cytochrome P450 Isoforms Cancer Res., January 1, 1999; 59(1): 91 - 98. [Abstract] [Full Text] [PDF]

				J. Zhang and X. Ding Identification and Characterization of a Novel Tissue-specific Transcriptional Activating Element in the 5'-Flanking Region of the CYP2A3 Gene Predominantly Expressed in Rat Olfactory Mucosa J. Biol. Chem., September 4, 1998; 273(36): 23454 - 23462. [Abstract] [Full Text] [PDF]

				J. Gu, Q.-Y. Zhang, M. B. Genter, T. W. Lipinskas, M. Negishi, D. W. Nebert, and X. Ding Purification and Characterization of Heterologously Expressed Mouse CYP2A5 and CYP2G1: Role in Metabolic Activation of Acetaminophen and 2,6-Dichlorobenzonitrile in Mouse Olfactory Mucosal Microsomes J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1287 - 1295. [Abstract] [Full Text]

				H. Hellmold, M. Magnusson, M. Pelto-Huikko, T. Rylander, J.-A. Gustafsson, and M. Warner Identification of CYP2A3 as a Major Cytochrome P450 Enzyme in the Female Peripubertal Rat Breast Mol. Pharmacol., March 1, 1998; 53(3): 475 - 482. [Abstract] [Full Text]

				L. L. Koenigs, R. M. Peter, S. J. Thompson, A. E. Rettie, and W. F. Trager Mechanism-Based Inactivation of Human Liver Cytochrome P450 2A6 by 8-Methoxypsoralen Drug Metab. Dispos., December 1, 1997; 25(12): 1407 - 1415. [Abstract] [Full Text]